Vaxxilon
Reinach · Founded 2015
About Vaxxilon
Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines. Headquartered near Basel, Switzerland with research labs in Berlin, the Vaxxilon team is advancing several vaccine candidates for the prevention of major infectious diseases.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.4M
- Funding stage: M&A
- Last round: Grant (Aug 2019)
- Website: http://vaxxilon.com/
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vaxxilon-170188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.